These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30123048)

  • 1. Urinary Orosomucoid A Potential Marker Of Inflammation In Psoriasis.
    Kustán P; Kőszegi T; Miseta A; Péter I; Ajtay Z; Kiss I; Németh B
    Int J Med Sci; 2018; 15(11):1113-1117. PubMed ID: 30123048
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring urinary orosomucoid in patients undergoing cardiac surgery: A promising novel inflammatory marker.
    Kustán P; Szirmay B; Kőszegi T; Ludány A; Kovács GL; Miseta A; Mühl D; Németh B; Kiss I; Németh Á; Szabados S; Ajtay Z
    Clin Biochem; 2017 Dec; 50(18):1002-1006. PubMed ID: 28736055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum and urinary orsomucoid protein A in psoriatic patients and their relation to severity of disease.
    Khalid HN; Abd El Gayed EM; Elrsool AMA; Bazid HAS
    J Cosmet Dermatol; 2022 Mar; 21(3):1185-1192. PubMed ID: 33905172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?
    Németh B; Péter I; Boncz I; Jagicza A; Kiss I; Csergő Á; Kőszegi T; Kustán P; Horváth IG; Ajtay Z
    Ther Clin Risk Manag; 2019; 15():831-837. PubMed ID: 31308681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary orosomucoid: a novel, early biomarker of sepsis with promising diagnostic performance.
    Kustán P; Szirmay B; Horváth-Szalai Z; Ludány A; Kovács GL; Miseta A; Kőszegi T; Mühl D
    Clin Chem Lab Med; 2017 Feb; 55(2):299-307. PubMed ID: 27816958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated urinary orosomucoid excretion as a novel biomarker in Crohn's disease.
    Szirmay B; Tárnok A; Sarlós P; Szigeti N; Ludány A; Kustán P; Horváth-Szalai Z; Miseta A; Kőszegi T
    Eur J Clin Invest; 2019 Mar; 49(3):e13054. PubMed ID: 30451301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary orosomucoid: validation of an automated immune turbidimetric test and its possible clinical use.
    Kustán P; Szirmay B; Horváth-Szalai Z; Ludány A; Lakatos Á; Mühl D; Christensen PH; Miseta A; Kovács GL; Kőszegi T
    Biochem Med (Zagreb); 2016 Oct; 26(3):421-430. PubMed ID: 27812309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Orosomucoid - 2 and Soluble CD14 as Potential Biomarkers for Assessment of Disease Activity in Rheumatoid Arthritis.
    Sabry R; El-Madbouly AA; Abozeid HE; Hassan MM
    Egypt J Immunol; 2018 Jun; 25(2):107-116. PubMed ID: 30600953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between orosomucoid (ORM) types and psoriasis.
    Fan C; Lidén S
    Hum Hered; 1994; 44(2):72-6. PubMed ID: 8188313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and Urinary Orosomucoid in Young Patients With Type 1 Diabetes: A Link Between Inflammation, Microvascular Complications, and Subclinical Atherosclerosis.
    El-Beblawy NM; Andrawes NG; Ismail EA; Enany BE; El-Seoud HS; Erfan MA
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):718-726. PubMed ID: 26975878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
    Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
    J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or inflammation in coronary artery disease.
    Fandiño-Vaquero R; Fernández-Trasancos A; Alvarez E; Ahmad S; Batista-Oliveira AL; Adrio B; Fernández AL; González-Juanatey JR; Eiras S
    Atherosclerosis; 2014 Aug; 235(2):281-8. PubMed ID: 24905138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
    Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
    Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential behaviour of epicardial adipose tissue-secretomes with high and low orosomucoid levels from patients with cardiovascular disease in H9C2 cells.
    Lage R; Moscoso I; Fernández-Trasancos Á; Cebro M; Couselo M; Fandiño-Vaquero R; Bravo SB; Sierra J; González-Juanatey JR; Eiras S
    Mol Cell Endocrinol; 2015 Nov; 416():77-87. PubMed ID: 26343163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis.
    Park YJ; Yoo SA; Hwang D; Cho CS; Kim WU
    Exp Mol Med; 2016 Feb; 48(2):e211. PubMed ID: 26915672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation.
    Colombo S; Buclin T; Décosterd LA; Telenti A; Furrer H; Lee BL; Biollaz J; Eap CB;
    Clin Pharmacol Ther; 2006 Oct; 80(4):307-18. PubMed ID: 17015049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
    Ataseven A; Kesli R
    G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes.
    Christiansen MS; Iversen K; Larsen CT; Goetze JP; Hommel E; Mølvig J; Pedersen BK; Magid E; Feldt-Rasmussen B
    Scand J Clin Lab Invest; 2009; 69(2):272-81. PubMed ID: 18972260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.
    Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
    Mediators Inflamm; 2017; 2017():9538451. PubMed ID: 28932021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.